The experience of diagnosis and treatment for TAFRO syndrome

Ann Hematol. 2023 Dec;102(12):3515-3520. doi: 10.1007/s00277-023-05435-8. Epub 2023 Sep 15.

Abstract

Early identification, diagnosis and treatment of TAFRO syndrome are very importants. We retrospectively analysed 6 patients with TAFRO syndrome. Their clinical manifestations, treatment methods, survival and other aspects were summarized. All patients were pathologically diagnosed with Castleman's disease, with fever, an inflammatory storm state and varying degrees of anasarca. All patients received steroid therapy; four of them also received chemotherapy, and 1 received rituximab. Of the 3 patients with severe disease, only 1 patient who received the recommended dose of glucocorticoids survived. Early administration of glucocorticoids can improve the prognosis, especially in patients with severe disease, and adequate glucocorticoids are important.

Keywords: Castleman; Clinical manifestations; Diagnosis; TAFRO syndrome.

MeSH terms

  • Castleman Disease* / diagnosis
  • Castleman Disease* / drug therapy
  • Edema
  • Glucocorticoids / therapeutic use
  • Humans
  • Retrospective Studies
  • Thrombocytopenia*

Substances

  • Glucocorticoids

Supplementary concepts

  • Multi-centric Castleman's Disease